Skip to content

A prospective cohort study on the prevention and treatment of children's bronchial asthma attack induced by acute upper respiratory tract infection with Qingfei Oral liquid based on realistic medical environment and Chinese Children's Asthma Action Plan

A prospective cohort study on the prevention and treatment of children's bronchial asthma attack induced by acute upper respiratory tract infection with Qingfei Oral liquid based on realistic medical environment and Chinese Children's Asthma Action Plan

Status
Active, not recruiting
Phases
Phase 4
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200060563
Enrollment
Unknown
Registered
2022-06-04
Start date
2022-05-30
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute upper respiratory tract infection induced bronchial asthma in children

Interventions

Exposed group:Standard treatment+Ertong Qingfei oral liquid
Unexposed group:Standard treatment

Sponsors

The First Teaching Hospital of Tianjin University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 17 Years

Inclusion criteria

Inclusion criteria: 1. Meet the "green zone" criteria for asthma; 2. Fever, stuffy nose, turbid nose, dry pharynx or pharynx pain and discomfort, cough, thick phlegm and other acute upper respiratory tract infection symptoms of 2 or more; 3. 3-17 years old (=8 years old should sign the informed consent with their guardian at the same time; 5. Agree to use the Leisurely Breathing APP.

Exclusion criteria

Exclusion criteria: 1. Patients with fatal asthma attack risk factors; 2. Children with contraindications in the application of Qingfei oral liquid (such as chronic cough, sweating and body deficiency) or children considered unsuitable for the use of Qingfei oral liquid by researchers.

Design outcomes

Primary

MeasureTime frame
Rate of acute asthma attack;Duration of acute asthma attack;Time to remission/rate of asthma attack;Proportion of children entering the "red zone";Frequency and dosage of asthma control and palliative drugs;

Countries

China

Contacts

Public ContactXinmin Li

The First Teaching Hospital of Tianjin University of TCM

tjtcmlxm@163.com+86 022-27986368

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026